STOCK TITAN

Evotec SE - EVO STOCK NEWS

Welcome to our dedicated news page for Evotec SE (Ticker: EVO), a resource for investors and traders seeking the latest updates and insights on Evotec SE.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Evotec SE's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Evotec SE's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.47%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.1%
Tags
partnership
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.54%
Tags
partnership
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.88%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.54%
Tags
partnership
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.54%
Tags
partnership
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.71%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.96%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.34%
Tags
acquisition
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.65%
Tags
partnership
Evotec SE

OTC:EVO

EVO Rankings

EVO Stock Data

2.77B
145.80M
1.61%
0.02%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Germany
Hamburg

About EVO

Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists.